Trial Search Results
Study to Intervene With Nutrition for Gastroparesis
The study is a self-controlled study in which we will assess the safety and efficacy of Kate Farm Peptide 1.5 tube feeding in patients with gastroparesis, relative to their pre-enrollment tube feeding regimen.
Stanford is currently accepting patients for this trial.
- Dietary Supplement: Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula
- Male or female gender
- Ages 18 to 65
- Established diagnosis of gastroparesis confirmed by gastric emptying study within the
last 2 years.
- No changes to gastroparesis medications in the 3 months prior to recruitment.
- Patients with hysterectomy, appendectomy, cholecystectomy and fundoplication are ok to
- Jejunostomy tube placed greater than or equal to 1 year prior to recruitment.
- Greater than or equal to 70% of daily caloric intake (DCI) from tube feeds.
- Able to give informed consent.
- Ability to adhere to the study visit schedule and other protocol requirements.
- Are nursing or pregnant.
- Diagnosis of mechanical small bowel obstruction within 3 months prior to recruitment.
- Patients with a history of gastric surgery, including gastrectomy, small bowel
resection or bariatric surgery.
- The use of narcotic medications in the month prior to study enrollment or during the
- Diagnosis of short gut syndrome.
- Diagnosis of small intestinal bacterial overgrowth.
Ages Eligible for Study
18 Years - 65 Years
Genders Eligible for Study